Group One Trading
TGTX icon

Group One Trading’s TG Therapeutics TGTX Stock Holding History

Group One Trading’s Portfolio TGTX Stock Details TGTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.1M Buy
334,000
+71,800
+27% +$2.14M 0.02% 779
2025
Q4 		$7.82M Buy
262,200
+26,800
+11% +$875K 0.01% 1122
2025
Q3 		$8.5M Sell
235,400
-3,100
-1% -$102K 0.02% 1029
2025
Q2 		$8.58M Sell
238,500
-97,100
-29% -$3.61M 0.02% 927
2025
Q1 		$13.2M Sell
335,600
-94,800
-22% -$3.19M 0.04% 488
2024
Q4 		$13M Sell
430,400
-31,900
-7% -$915K 0.03% 553
2024
Q3 		$10.8M Sell
462,300
-49,300
-10% -$1.08M 0.03% 584
2024
Q2 		$9.1M Buy
511,600
+75,200
+17% +$1.2M 0.04% 489
2024
Q1 		$6.64M Sell
436,400
-295,100
-40% -$4.7M 0.03% 649
2023
Q4 		$12.5M Buy
731,500
+65,000
+10% +$755K 0.03% 566
2023
Q3 		$5.57M Buy
666,500
+113,700
+21% +$1.59M 0.02% 880
2023
Q2 		$13.7M Sell
552,800
-8,500
-2% -$220K 0.04% 372
2023
Q1 		$8.44M Sell
561,300
-973,500
-63% -$14.8M 0.03% 569
2022
Q4 		$18.2M Buy
1,534,800
+68,500
+5% +$497K 0.04% 447
2022
Q3 		$8.68M Sell
1,466,300
-215,000
-13% -$1.41M 0.02% 816
2022
Q2 		$7.15M Buy
1,681,300
+985,000
+141% +$6.15M 0.01% 1069
2022
Q1 		$6.62M Buy
696,300
+190,000
+38% +$2.2M 0.01% 1312
2021
Q4 		$9.62M Sell
506,300
-89,400
-15% -$2.32M 0.01% 1137
2021
Q3 		$19.8M Buy
595,700
+94,500
+19% +$2.92M 0.02% 626
2021
Q2 		$19.4M Buy
501,200
+18,900
+4% +$742K 0.02% 646
2021
Q1 		$23.2M Sell
482,300
-276,200
-36% -$13.3M 0.03% 472
2020
Q4 		$39.5M Buy
758,500
+172,400
+29% +$5.82M 0.07% 240
2020
Q3 		$15.7M Sell
586,100
-104,200
-15% -$2.4M 0.05% 358
2020
Q2 		$13.4M Buy
690,300
+6,500
+1% +$105K 0.06% 346
2020
Q1 		$6.73M Buy
683,800
+208,300
+44% +$2.63M 0.05% 398
2019
Q4 		$5.28M Buy
475,500
+249,000
+110% +$1.89M 0.04% 653
2019
Q3 		$1.27M Sell
226,500
-102,600
-31% -$715K 0.01% 1550
2019
Q2 		$2.85M Buy
329,100
+161,800
+97% +$1.22M 0.03% 848
2019
Q1 		$1.34M Buy
167,300
+51,000
+44% +$276K 0.02% 1201
2018
Q4 		$477K Sell
116,300
-57,400
-33% -$285K ﹤0.01% 2015
2018
Q3 		$973K Buy
173,700
+59,400
+52% +$679K 0.01% 1720
2018
Q2 		$1.5M Sell
114,300
-4,300
-4% -$59.1K 0.01% 1335
2018
Q1 		$1.68M Sell
118,600
-38,900
-25% -$497K 0.02% 1127
2017
Q4 		$1.29M Buy
157,500
+35,700
+29% +$312K 0.01% 1512
2017
Q3 		$1.44M Sell
121,800
-18,400
-13% -$210K 0.01% 1297
2017
Q2 		$1.41M Sell
140,200
-40,000
-22% -$448K 0.01% 1197
2017
Q1 		$2.1M Buy
180,200
+179,100
+16,282% +$1.29M 0.02% 835
2016
Q4 		$5K Hold
1,100
– – ﹤0.01% 4105
2016
Q3 		$9K Sell
1,100
-17,900
-94% -$115K ﹤0.01% 4079
2016
Q2 		$115K Buy
19,000
+9,500
+100% +$77.2K ﹤0.01% 2767
2016
Q1 		$81K Sell
9,500
-27,200
-74% -$238K ﹤0.01% 2974
2015
Q4 		$438K Sell
36,700
-5,400
-13% -$68.2K 0.01% 1920
2015
Q3 		$424K Sell
42,100
-6,400
-13% -$95.4K 0.01% 1905
2015
Q2 		$805K Sell
48,500
-5,800
-11% -$91.8K 0.01% 1395
2015
Q1 		$841K Sell
54,300
-21,600
-28% -$327K 0.01% 1214
2014
Q4 		$1.2M Buy
75,900
+3,300
+5% +$43K 0.02% 958
2014
Q3 		$775K Buy
72,600
+6,900
+11% +$64K 0.01% 1278
2014
Q2 		$617K Buy
65,700
+44,700
+213% +$286K 0.01% 1481
2014
Q1 		$145K Buy
21,000
+7,400
+54% +$43.8K ﹤0.01% 2723
2013
Q4 		$53K Buy
+13,600
New +$54.9K ﹤0.01% 3569

Other funds holding TGTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Group One Trading's TGTX Position: Q1 2026 in Review

Group One Trading reduced its TG Therapeutics (TGTX) stake by 80% in Q1 2026, selling an estimated $5.46M and leaving 45,240 shares worth $1.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2337.

Group One Trading first reported a position in TGTX in Q4 2013 and has held it in 49 quarters since. The position peaked at $56.3M in Q3 2021. 363 funds tracked by Wall St. Rank hold TGTX as of Q1 2026.

  • Group One Trading held 45,240 shares of TG Therapeutics worth $1.5M as of Q1 2026.
  • Group One Trading sold 183,267 TG Therapeutics shares in Q1 2026, an estimated $5.46M.
  • TG Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #2337 holding.
  • Group One Trading first reported a position in TG Therapeutics in Q4 2013 and has held it in 49 quarters since.
  • Group One Trading's TG Therapeutics position peaked at $56.3M in Q3 2021.
  • 363 funds tracked by Wall St. Rank held TG Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.